Crestwood Advisors Group LLC Astrazeneca PLC Transaction History
Crestwood Advisors Group LLC
- $4.5 Billion
- Q1 2024
A detailed history of Crestwood Advisors Group LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Crestwood Advisors Group LLC holds 5,482 shares of AZN stock, worth $431,488. This represents 0.01% of its overall portfolio holdings.
Number of Shares
5,482
Previous 4,139
32.45%
Holding current value
$431,488
Previous $278,000
33.45%
% of portfolio
0.01%
Previous 0.01%
Shares
2 transactions
Others Institutions Holding AZN
# of Institutions
1,269Shares Held
483MCall Options Held
5.99MPut Options Held
5.22M-
Price T Rowe Associates Inc Baltimore, MD61.3MShares$4.82 Billion0.51% of portfolio
-
Wellington Management Group LLP Boston, MA49.1MShares$3.87 Billion0.6% of portfolio
-
Primecap Management CO Pasadena, CA42.9MShares$3.38 Billion2.21% of portfolio
-
Capital International Investors Los Angeles, CA34.5MShares$2.72 Billion0.48% of portfolio
-
Jennison Associates LLC17.3MShares$1.36 Billion0.79% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $244B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...